PDE5 inhibitor (background therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PDE5 inhibitor (background therapy), covering 2012-07-30 to 2012-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1) [Phase 4]